secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001477932-25-008402
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health Q3 2025 revenue $17.1M (+38% YoY), record gross margin 15.2%, cash jumps to $4.63M
--------------------------------------------------------------------------------

- Q3 2025 revenue $17.11M (up 38% YoY); gross profit $2.60M (+116%), gross margin 15.21% (vs 9.72%).
- Adjusted EBITDA loss narrowed 74% to ($0.19M); adjusted EPS $(0.02) vs $(0.34) a year ago.
- Cash and cash equivalents surged to $4.63M from $0.66M at June 30, 2025.
- Secured $300M digital financing facility and commenced Ethereum purchases.
- Contract manufacturing agreement for 3M MYCOFAGYL pessaries annually; Sky Premium Life enters Oman.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793225008402/0001477932-25-008402-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793225008402/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-008402

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer